Search for: "NOVARTIS AG"
Results 141 - 160
of 439
Sort by Relevance
|
Sort by Date
13 Nov 2015, 7:43 am
In fact, it may have been Novartis AG’s concerns about close competitor Roche that led to their deceptive – and illegal – practices. [read post]
3 Nov 2015, 12:13 pm
Novartis AG, a European based pharmaceutical company, agreed to settle a False Claims Act (FCA) lawsuit for $390 million, a week before the original $3.3 billion FCA lawsuit was set to go to trial on November 2, 2015. [read post]
3 Nov 2015, 9:00 am
(Novartis), a subsidiary of Novartis AG, an international pharmaceutical company headquartered in Switzerland, agreed to pay a whopping $390 million as a "settlement in principle" to resolve a False Claims Act (FCA) suit. [read post]
3 Nov 2015, 9:00 am
(Novartis), a subsidiary of Novartis AG, an international pharmaceutical company headquartered in Switzerland, agreed to pay a whopping $390 million as a "settlement in principle" to resolve a False Claims Act (FCA) suit. [read post]
3 Nov 2015, 9:00 am
(Novartis), a subsidiary of Novartis AG, an international pharmaceutical company headquartered in Switzerland, agreed to pay a whopping $390 million as a "settlement in principle" to resolve a False Claims Act (FCA) suit. [read post]
3 Nov 2015, 4:00 am
Novartis AG, a European based pharmaceutical company, agreed to settle a False Claims Act (FCA) lawsuit for $390 million, a… The post European Pharmaceutical Giant Novartis Settles False Claims Act Whistleblower Case for $390 Million appeared first on TZ Legal - Fraud Fighters. [read post]
9 Oct 2015, 7:08 am
Medscape reports that a Food and Drug Administration advisory panel recommended approval of Novartis’ new influenza vaccine “that promises to offer enhanced effectiveness in patients aged over 65 years. [read post]
23 Sep 2015, 9:59 pm
By Kevin E. [read post]
28 Aug 2015, 8:08 pm
Noonan Counsel for Amicus Curiae -- brief • Novartis AG, Corey A. [read post]
26 May 2015, 7:42 am
(Emphasis added).FDA Regulation of Pharmacogenomic InformationWe still feel the same way, but now with the caveat that the FDA is starting to lay the regulatory foundation for drug warnings in the coming age of personalized medicine. [read post]
25 May 2015, 4:15 am
.* When functionality cuts deep, it can be hard to handle: Yoshida appeal dismissedValentina's back again to pen on General Court's decision in Joined Cases C‑337/12 P to C‑340/12 P Pi-Design AG, Bodum France SAS and Bodum Logistics A/S v OHIM, Yoshida Metal Industry Co. [read post]
18 May 2015, 11:01 am
| OHIM’s rebranding | LV’s pattern as trade mark | EPO and trade unions | Patent and first-mover advantage | Libraries’ right to digitise their collection in Germany.Never too late 42 [week ending on Sunday 19 April] – WIPO Roving Seminars in Israel | Foster v Svenson, or "of taking pictures of your neighbours" | Trade marks and social networks | Jan Rosen on CJEU's public criterion to assess whether linking amounts communication to the… [read post]
11 May 2015, 3:05 pm
| OHIM’s rebranding | LV’s pattern as trade mark | EPO and trade unions | Patent and first-mover advantage | Libraries’ right to digitise their collection in Germany.Never too late 42 [week ending on Sunday 19 April] – WIPO Roving Seminars in Israel | Foster v Svenson, or "of taking pictures of your neighbours" | Trade marks and social networks | Jan Rosen on CJEU's public criterion to assess whether linking amounts communication to the… [read post]
3 May 2015, 10:33 pm
.* No toleration for Novartis - rivastigmine patch patent declared invalidDarren writes up Mr Justice Arnold’s fresh decision in Novartis v Focus, Actavis, Teva [2015] EWHC 1068 (Pat).No cats are skinned, but publisher is "Berned" for Chesterton infringementValentina reports on a Spanish Supreme Court’s decision in a very peculiar Spanish copyright case, where the principle of non-discrimination is addressed and a copyright term of protection is held… [read post]
31 Mar 2015, 4:01 pm
They would mean that libraries can acquire and lend commercially available digital materials and, with archives, can continue to underpin knowledgeable societies in the digital age. [read post]
19 Mar 2015, 5:00 am
Novartis AG, ___ F. [read post]
16 Mar 2015, 9:59 pm
Reg. 1346) to revise the rules of practice to implement the Federal Circuit's decision in Novartis AG v. [read post]
3 Mar 2015, 1:55 am
Counsel for Pfizer drew analogy between this situation and “the situation where an injunction is sought pending appeal even though the patent has been held invalid at first instance, as to which see Novartis AG v Hospira UK Ltd [2013] EWCA Civ 583, [2014] 1 WLR 1264. [read post]
2 Mar 2015, 2:43 pm
| Dutch diverge with English as Novartis prevails on Zoledronic Acid in Netherlands | Slogan and TMs | The coffee capsule wars | Declining public trust in innovation | IPEC’s ruling in Global Flood Defence Systems& Another v Van den Noort Innovations BV & Others | Again on CJEU ruling in Case C-419/13 Art & Allposters | Biotech financing: the risk components, ‘going long’ and patents as knowledge currency. [read post]
23 Feb 2015, 2:55 am
| Dutch diverge with English as Novartis prevails on Zoledronic Acid in Netherlands | Slogan and TMs | The coffee capsule wars | Declining public trust in innovation | IPEC’s ruling in Global Flood Defence Systems & Another v Van den Noort Innovations BV & Others | Again on CJEU ruling in Case C-419/13 Art & Allposters | Biotech financing: the risk components, ‘going long’ and patents as knowledge currency. [read post]
